Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:DSCI’

Most Affordable Medical Schools in Europe

Derma Sciences Inc (DSCI): Smart Money Continues to Abandon the Stock

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers......(read more)

13G Filing: RA Capital Management and Derma Sciences, Inc. (DSCI)

In a new filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital Management disclosed a position in Derma Sciences Inc......(read more)
Jeff Smith

Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI)

Some bright minds of the finance world believe that shareholder activism has surged in recent years because of increased market efficiency. Hedge funds......(read more)
Felix Baker - Baker Bros.

Is Derma Sciences Inc (DSCI) a Good Buy?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on......(read more)
Broadfin Kevin Kotler

Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI)

In two separate filings today Kevin Kotler‘s Broadfin Capital has revealed increasing its passive stake in Zogenix, Inc. (NASDAQ:ZGNX) to 10.74......(read more)

Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners

Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund......(read more)

Ra Capital Management Lowers Stake in Derma Sciences Inc (DSCI)

Peter Kolchinsky‘s Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI). Following the disposal......(read more)
Broadfin Kevin Kotler

Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported......(read more)
BLUE RIDGE CAPITAL

5 Stocks Hedge Funds Bought Recently

Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average. In this article we will focus on 5......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)

Kevin Kotler‘s Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI). According to a new filing with the SEC, Broadfin......(read more)

Osiris Therapeutics, Inc. (OSIR), Derma Sciences Inc (DSCI): The Changing Landscape in Chronic Diabetic Foot Ulcers

While the market of treating chronic diabetic foot ulcers is by no means glamorous, it can still be a very lucrative indication. Some estimates have put......(read more)
Harvard Bioscience Inc. (HBIO)

Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds’ portfolio at the end of March. HBIO shareholders have witnessed an increase in activity......(read more)

This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)

Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds’ portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm......(read more)

AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?

AtriCure Inc. (NASDAQ:ATRC) has experienced an increase in enthusiasm from smart money of late. In today’s marketplace, there are tons of indicators......(read more)

BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?

BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds’ portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease......(read more)

Derma Sciences Inc (DSCI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Derma Sciences Inc (NASDAQ:DSCI) has experienced an increase in hedge fund interest of late. At the moment, there are a multitude of indicators investors......(read more)